Clinicians, laboratorians, and patients have one goal in common - improving healthcare. Autoimmune diseases are challenging to diagnose due to the seronegative gap, often leading to delays in treatment for the patient.
With the development of new biomarkers and technologies, patients can receive a more accurate, earlier diagnosis including valuable information regarding risk stratification. We will discuss new biomarkers for autoimmune disease and present an advanced technology for multi-analyte testing.
WHEN: Tuesday, August 6th, 2019
TIME: 7:00 - 8:30 am
WHERE: Hilton Anaheim Hotel California Ballroom B, 2nd floor
Come early at 6:45 am and join us for a light breakfast.
Registered attendees are eligible for 1.5 CEU credit.